Atomic has officially launched as a service model designed to help MedTech startups transition from early-stage innovation to investor-ready ventures. The new platform, developed through a collaboration among industry leaders Goodwin, Three Bridges, and Match Health Collective, offers a fully integrated suite of legal, financial, and strategic services that equip founders to navigate today’s complex venture landscape.
Headquartered in San Francisco, Boston, and Milan, Atomic provides founders with an unprecedented level of alignment across critical business functions. Its fixed-fee, zero-equity structure allows startups to retain full ownership while gaining access to essential deliverables such as IP strategy, financial modeling, investor presentations, and branding materials. This approach is tailored for a select number of high-potential MedTech companies seeking to secure venture capital more efficiently.
The launch comes amid a shifting funding environment where early-stage MedTech founders face heightened scrutiny from investors who are delaying capital commitments and demanding robust operational readiness. Atomic’s model directly addresses this market gap by offering deep, coordinated expertise across disciplines that traditionally operate in silos.
Unlike traditional accelerators or consultancies, Atomic’s focus is on tangible outcomes rather than general mentorship. Each client program is customized to the company’s development stage and business objectives, with ongoing access to investor networks, media visibility, and strategic growth opportunities. The firm positions itself as a long-term partner to its portfolio companies, continuing to advise them through future fundraising and scaling milestones.
The success of Atomic’s first cohort is already evident. Contrario Medical, the inaugural company to complete the program, raised $2.3 million in seed funding within five weeks, signaling the effectiveness of the model in driving measurable investor confidence.
Goodwin, Atomic’s legal co-founder, brings decades of experience advising MedTech companies through the whole business life cycle—from formation to exit. Its specialized expertise across corporate law, IP, regulatory compliance, and M&A provides the legal backbone of Atomic’s integrated offering.
KEY QUOTE:
“After supporting countless VC financings over the years, the biggest challenge we see for MedTech companies that come to us is the significant gap between innovative technology and a real fundable business. By aligning legal, financial, and market strategy from the outset, we help a select group of founders show up ready for investors and positioned to lead the next generation of MedTech innovation.”
Marty Gomez, Partner at Goodwin and Co-Founder of Atomic
